Published in Blood Weekly, December 3rd, 2009
"This results in qualitative or quantitative abnormalities of the platelet receptor, alpha IIb-beta 3. The aim of this study was to identify the mutations in GT patients and to correlate these with patient phenotype. A total of 45 unrelated patients with GT were enrolled in the present study to identify the causative molecular defects, and also...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.